All Curated Mutation Sites in HCMV

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HCMV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Keyword: Cytomegalovirus infections-19712701

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	19712701	C511R	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
2	19712701	D118V	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
3	19712701	D605E	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
4	19712701	F102L	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
5	19712701	I244V	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
6	19712701	I533V	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
7	19712701	M330T	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
8	19712701	M460V	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	D R	View
9	19712701	M526I	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
10	19712701	N68D	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
11	19712701	R507P	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View
12	19712701	T400A	UL97	UL97	Immunocompromised Host Cytomegalovirus infections	R	View

Contents
Description

The table shows all curated mutation sites of HCMV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.